This is to inform you that pursuant to Regulation 30 read with Regulation 33 of the Listing Regulations, the Board at its meeting held today i.e., Friday, May 15, 2026, through video Conferencing, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Globalspace Technologies Ltd convened on May 15, 2026 and approved key decisions. Financially, the company reported a strong turnaround with standalone net profit of Rs 136.49 lakhs (vs loss of Rs 183.73 lakhs in FY25) and consolidated net profit of Rs 285.23 lakhs (vs loss of Rs 199.92 lakhs in FY25). Total income grew 13.7% standalone (Rs 3,335.63L) and 20.4% consolidated (Rs 5,186.10L). Ms. Tania Mazumdar was appointed as CEO and KMP for 3 years - she brings 22+ years of experience in pharmaceuticals and digital health. The Board also re-appointed Maheshwari Maheshwari & Co. as internal auditor for FY 2026-27 and granted 4,90,000 stock options to eligible employees under the ESOS 2018 scheme.
The company has demonstrated a remarkable turnaround with both profitability and revenue growth. The new CEO appointment and ESOP grant signal strategic intent in the pharmaceutical and digital health space. The improved debt-equity ratio (0.06 from 0.18) and strong cash generation from operations (Rs 218.66 cr standalone) indicate a healthier balance sheet.